Donaldson Expands Lab at Minnesota Headquarters
Donaldson Company, Inc. announced a $10 million expansion of its testing laboratories at its Bloomington, Minn., corporate headquarters.
Donaldson Company, Inc. a manufacturer of filtration systems and replacement parts, announced a $10 million expansion of its testing laboratories at its Bloomington, Minn., corporate headquarters. Expected to be fully operational in 2014, expansions will enhance Donaldson's capabilities for testing filter performance under various environmental conditionst.
The expansions will enhance current capabilities to test products in real world environments, factoring in multiple variables at one time such as: temperature, humidity, vibration, pulsation and flow as well as various contaminants. This will allow Donaldson's in-house scientists and engineers to speed development time and decrease costs, while increasing product effectiveness and reliability, the company reports in a statement.
Source: Donaldson Company Inc.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
